Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

279
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
279
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

406
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
406
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

372
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
372
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

239
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
239
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

359
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
359
Venous Return01:04

Venous Return

11.6K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
11.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Catastrophic Pediatric Stroke Following Attempted Transcatheter Ventricular Septal Defect Closure.

JACC. Case reports·2026
Same author

Leadless atrial pacemaker implantation after covered stent correction for superior sinus venous defect-A case report.

HeartRhythm case reports·2026
Same author

Transcatheter Repair of Sinus Venosus Defect Using a 12-zig Covered Cheatham-Platinum Stent in Large Superior Vena Cava-Right Atrium Junctions: Early Multicenter Experience.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Percutaneous Interventions for Heart Failure in Congenital Heart Disease.

Current cardiology reports·2026
Same author

International Experience of Transcatheter Sinus Venosus Defect Closure in Children and Adolescents.

Pediatric cardiology·2026
Same author

Case Report: Transcatheter occlusion of a rare pulmonary artery to left atrium fistula using an atrial septal defect occluder device.

Frontiers in cardiovascular medicine·2026

Related Experiment Video

Updated: Jan 13, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.2K

VenusP-Valve: Outcomes Beyond 5 Years.

Reem Rashed1,2, Matthew I Jones1, Pimpak Prachasilchai3

  • 1Department of Congenital Cardiology, Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|January 8, 2026
PubMed
Summary
This summary is machine-generated.

Percutaneous pulmonary valve implantation (PPVI) using the VenusP-valve shows excellent mid-term results for right ventricular outflow tracts. This transcatheter approach offers a safe alternative to surgery with sustained functional improvements.

Keywords:
percutaneous pulmonary valve implantation (PPVI)pulmonary regurgitation (PR)pulmonary valve replacement (PVR)right ventricular outflow tract (RVOT) dysfunction

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

523
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.6K

Related Experiment Videos

Last Updated: Jan 13, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.2K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

523
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.6K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Percutaneous pulmonary valve implantation (PPVI) provides a surgical alternative for dysfunctional right ventricular outflow tracts (RVOTs).
  • The VenusP-valve is a self-expanding transcatheter valve designed for larger RVOTs, available in diameters from 24 to 36 mm.

Purpose of the Study:

  • To evaluate the medium to long-term outcomes of the VenusP-valve in patients undergoing PPVI.
  • To assess patient results and the durability of the VenusP-valve in treating severe pulmonary regurgitation.

Main Methods:

  • A retrospective review of 58 patients with severe pulmonary regurgitation (PR) who underwent attempted PPVI with the VenusP-valve between October 2013 and September 2018.
  • Data collected included patient characteristics, clinical outcomes, imaging results, and follow-up status from two international centers.

Main Results:

  • Successful PPVI was achieved in 96.6% of patients; one failure and one valve migration required surgery.
  • No early or late deaths, valve stenosis, severe PR, infective endocarditis, or significant ventricular arrhythmias were observed.
  • Wire frame fractures occurred in 23.2% of valves but did not impact function. Significant improvements in PR and RV volumes were sustained at 6-12 months post-procedure.

Conclusions:

  • VenusP-valve implantation demonstrates excellent early and mid-term outcomes with no major valve-related complications.
  • The valve shows sustained functional benefits over a 5-10 year period.
  • Longer-term follow-up is necessary to fully determine the performance and longevity of the VenusP-valve.